By Mr. Vijender Reddy Muthyala, Co-founder & CEO, DrinkPrimeEach year, our planet suffers from the burden of human-generated waste, mainly from plastic waste. Shockingly, according to research, humans produce over 350 million metric tons of plastic waste annually - a staggering volume. What's even more
The babies were admitted to a private Hospital in Khurda, located 40km away from Bhubaneswar, and were a case of suspected inborn error of metabolism (a genetic disease) with a poor chance of survival~~Twin babies were shifted to Ankura Hospital, Bhubaneswar for prompt management. Inborn Errors of Metabolism affect an estimated 50.9 per
Neuberg Diagnostics, one of the top 4 Pathology laboratory chains in India, with more than 200 labs and 2000+ collection centers and having a presence in India, South Africa, UAE, and the USA has joined forces with Sehgal Path Lab in a strategic joint venture aimed
By- Dr. Rachit Saxena, Senior Consultant, Cardiac Surgery, Narayana Hospital, GurugramChest pain is probably one of the most dreaded symptoms in the current era surrounded by news of sudden death following brief episodes of chest pain of varying severity. This chest pain is most of
It is a testament of SSi Mantra’s technological prowess and superiority, says Dr. Sudhir SrivastavaSS Innovations, the developer of India’s first surgical robotic system, the SSi Mantra, dedicated to making robotic surgeries cost-effective and accessible to a global population, today announced a milestone achievement
Tata Power Community Development Trust (TPCDT) has partnered with Tata Elxsi, a global leader in design and technology services, to drive their "Pay Autention" initiative forward. Leveraging Tata Elxsi's innovative digital therapeutics (DTx) solution, TEcare, TPCDT aims to accelerate the development of the India Neurodiversity
Novo Nordisk's widely used diabetes drug Ozempic delayed progression of chronic kidney disease in diabetes patients, a large late-stage study found, cutting the risk of death from that and major cardiac events by 24%. The trial results are the latest indication that drugs from the GLP-1
A weekly injection of semaglutide was safe and reduced by 31% of liver fat in patients with HIV and liver disease-as per data from a mid-stage study presented by the National Institutes of Health showed. Data from the study was first released on Monday at the
The U.S. Food and Drug Administration (FDA) has cleared the use of Dexcom's (DXCM.O), opens new tab device, making it the first continuous glucose monitor to be available over the counter, the health regulator said on Tuesday. Dexcom's shares experienced a surge of 2.2% in extended
Four children born with HIV were able to live virus-free for more than a year after their HIV medication was paused, as per study funded by the National Institutes of Health. The results of the P1115 study were announced on Wednesday at the 2024 Conference on
